149 related articles for article (PubMed ID: 36047147)
21. Toward the realization of a better aged society: messages from gerontology and geriatrics.
Arai H; Ouchi Y; Yokode M; Ito H; Uematsu H; Eto F; Oshima S; Ota K; Saito Y; Sasaki H; Tsubota K; Fukuyama H; Honda Y; Iguchi A; Toba K; Hosoi T; Kita T;
Geriatr Gerontol Int; 2012 Jan; 12(1):16-22. PubMed ID: 22188494
[TBL] [Abstract][Full Text] [Related]
22. Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.
Tetsuka K; Ohbuchi M; Kawabe T; Goto T; Kiyonaga F; Takama K; Yamazaki S; Fujimori A
Biol Pharm Bull; 2020; 43(3):375-383. PubMed ID: 32115499
[TBL] [Abstract][Full Text] [Related]
23. Leveraging microphysiological systems to address challenges encountered during development of oligonucleotide therapeutics.
Ramsden D; Belair DG; Agarwal S; Andersson P; Humphreys S; Dalmas DA; Stahl SH; Maclauchlin C; Cichocki JA
ALTEX; 2022; 39(2):273–296. PubMed ID: 34766620
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.
Frazier T; Williams C; Henderson M; Duplessis T; Rogers E; Wu X; Hamel K; Martin EC; Mohiuddin O; Shaik S; Devireddy R; Rowan BG; Hayes DJ; Gimble JM
Tissue Eng Part A; 2021 Apr; 27(7-8):479-488. PubMed ID: 33528293
[TBL] [Abstract][Full Text] [Related]
25. Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery.
Bai J; Wang C
Front Pharmacol; 2020; 11():407. PubMed ID: 32317971
[TBL] [Abstract][Full Text] [Related]
26. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
[TBL] [Abstract][Full Text] [Related]
27. Advanced Materials and Sensors for Microphysiological Systems: Focus on Electronic and Electrooptical Interfaces.
Kavand H; Nasiri R; Herland A
Adv Mater; 2022 Apr; 34(17):e2107876. PubMed ID: 34913206
[TBL] [Abstract][Full Text] [Related]
28. Microphysiological System Design: Simplicity Is Elegance.
Hinman SS; Kim R; Wang Y; Phillips KS; Attayek PJ; Allbritton NL
Curr Opin Biomed Eng; 2020 Mar; 13():94-102. PubMed ID: 32095672
[TBL] [Abstract][Full Text] [Related]
29. Applications of the microphysiology systems database for experimental ADME-Tox and disease models.
Schurdak M; Vernetti L; Bergenthal L; Wolter QK; Shun TY; Karcher S; Taylor DL; Gough A
Lab Chip; 2020 Apr; 20(8):1472-1492. PubMed ID: 32211684
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS).
Ueno R; Kuninori M; Sumi T; Sadeghian RB; Takata Y; Iguchi A; Tsuda M; Yamashita F; Ichikawa K; Yokokawa R
Micromachines (Basel); 2023 Mar; 14(4):. PubMed ID: 37420994
[TBL] [Abstract][Full Text] [Related]
31. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
[TBL] [Abstract][Full Text] [Related]
32. Organs-on-a-Chip.
Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
[TBL] [Abstract][Full Text] [Related]
33. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
Low LA; Tagle DA
Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
[TBL] [Abstract][Full Text] [Related]
34. Microphysiological systems as reliable drug discovery and evaluation tools: Evolution from innovation to maturity.
Moon HR; Surianarayanan N; Singh T; Han B
Biomicrofluidics; 2023 Dec; 17(6):061504. PubMed ID: 38162229
[TBL] [Abstract][Full Text] [Related]
35. Organ-on-a-chip technologies for biomedical research and drug development: A focus on the vasculature.
Veliz DS; Lin KL; Sahlgren C
Smart Med; 2023 Feb; 2(1):e20220030. PubMed ID: 37089706
[TBL] [Abstract][Full Text] [Related]
36. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
[TBL] [Abstract][Full Text] [Related]
37. Application of microphysiological systems for nonclinical evaluation of cell therapies.
Candarlioglu P; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan K; Fellows MD; Pointon A; Kojala K
ALTEX; 2024 May; ():. PubMed ID: 38746991
[TBL] [Abstract][Full Text] [Related]
38. Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism.
Lee DW; Lee SH; Choi N; Sung JH
Biotechnol Bioeng; 2019 Dec; 116(12):3433-3445. PubMed ID: 31429925
[TBL] [Abstract][Full Text] [Related]
39. Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing.
Chen WY; Evangelista EA; Yang J; Kelly EJ; Yeung CK
Front Pharmacol; 2021; 12():695920. PubMed ID: 34381363
[TBL] [Abstract][Full Text] [Related]
40. 4th Annual Predictive Toxicology Summit 2012.
Cui Z
Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):1061-6. PubMed ID: 23705810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
